COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS

摘要

The present disclosure is generally directed to antiviral compounds, and more specifically directed to compositions of compounds which can inhibit Hepatitis C virus (HCV) and methods for treating hepatitis C using such combinations. The composition comprises a therapeutically effective amount of the compound of formula (I)or a pharmaceutically acceptable salt thereof; a therapeutically effective amount of the compound of formula (II)or a pharmaceutically acceptable salt thereof; a therapeutically effective amount of the compound of formula (III)or a pharmaceutically acceptable salt thereof, and a therapeutically acceptable carrier.